Pfizer's (PFE) Biohaven agreed to a nearly $60 million nationwide settlement for submitting false claims to Medicaid and other government healthcare programs, California Attorney General Rob Bonta said Monday.
The settlement resolves allegations that Biohaven engaged in a kickback scheme from 2020 to 2022, offering cash and gifts to healthcare providers in exchange for Nurtec prescriptions, according to the Bonta.
Pfizer will make the payment of $59.7 million plus interest on behalf of Biohaven and it will be shared by the federal government and several states including California, whose share is $413,776, the state's Attorney General added.
Neither Pfizer nor Biohaven immediately responded to MT Newswires' requests for comment.
Price: 26.26, Change: -0.26, Percent Change: -0.98
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.